Evidence map›Paper›PMID 26676230›Full record

ArticleBBA clinical2014

Mutation of EMG1 causing Bowen-Conradi syndrome results in reduced cell proliferation rates concomitant with G2/M arrest and 18S rRNA processing delay.

Joy Armistead, Richard Hemming, Nehal Patel, Barbara Triggs-Raine

Open access · hybridAbstract read
In one paragraph

Article in BBA clinical, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Ribosome biogenesis and function in development and disease.Development (Cambridge, England) · 2023
    Review
  6. The homeostatic regulation of ribosome biogenesis.Seminars in cell & developmental biology · 2023
    Review
  7. Roles of ribosomal RNA in health and disease.Frontiers in RNA research · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Joy ArmisteadDepartment of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada ; Manitoba Institute of Child Health, Winnipeg, Manitoba, Canada.
Richard HemmingDepartment of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada.
Nehal PatelDepartment of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada.
Barbara Triggs-RaineDepartment of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada ; Manitoba Institute of Child Health, Winnipeg, Manitoba, Canada.
Children's Hospital Research Institute of Manitoba · CAUniversity of Manitoba · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bowen-Conradi syndrome (BCS) is a lethal autosomal recessive disorder caused by a D86G substitution in the protein, Essential for Mitotic Growth 1 (EMG1). EMG1 is essential for 18S rRNA maturation and 40S ribosome biogenesis in yeast, but no studies of its role in ribosome biogenesis have been done in mammals. To assess the effect of the EMG1 mutation on cell growth and ribosomal biogenesis in humans, we employed BCS patient cells. The D86G substitution did not interfere with EMG1 nucleolar localization. In BCS patient lymphoblasts, cells accumulated in G2/M, resulting in reduced proliferation rates; however, patient fibroblasts showed normal proliferation. The rate of 18S rRNA processing was consistently delayed in patient cells, although this did not lead to a difference in the levels of 40S ribosomes, or a change in protein synthesis rates. These results demonstrate that as in yeast, EMG1 in mammals has a role in ribosome biogenesis. The obvious phenotype in lymphoblasts compared to fibroblasts suggests a greater need for EMG1 in rapidly dividing cells. Tissue-specific effects have been seen in other ribosomal biogenesis disorders, and it seems likely that the impact of EMG1 deficiency would be larger in the rapidly proliferating cells of the developing embryo.

Indexed as

BCS, Bowen–Conradi syndromeBowen–Conradi syndromeCell proliferationCPM, counts per minuteEMG1EMG1, Essential for Mitotic Growth 1IRES, internal ribosomal entry site.m1acp3-ψ, N1-methyl-N3-(3-amino-3-carboxypropyl) pseudouridineRibosome biogenesisRibosomopathyrRNASAM, S-adenosylmethioninesnoRNA, small nucleolar RNA

Identifiers

PMID26676230
PMCPMC4633970
OpenAlexW2071785498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.